SCN2A-DEE

Neurology

9 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Relutrigine	Praxis Precision Medicines, Inc. (PRAX)

Preclinical(3)

Drug	Company
PRAX-080	Praxis Precision Medicines, Inc. (PRAX)
PRAX-090	Praxis Precision Medicines, Inc. (PRAX)
PRAX-100	Praxis Precision Medicines, Inc. (PRAX)

Phase 1/Phase 2(4)

Drug	Company
PRAX-222 - Fixed Doses	Praxis Precision Medicines, Inc. (PRAX)
PRAX-222 - Initial Ascending Doses	Praxis Precision Medicines, Inc. (PRAX)
PRAX-222 - Initial Dose	Praxis Precision Medicines, Inc. (PRAX)
PRAX-222 - Optional Ascending Doses	Praxis Precision Medicines, Inc. (PRAX)

Phase 2/Phase 3(1)

Drug	Company
PRAX-020	Praxis Precision Medicines, Inc. (PRAX)

BioSniper tracks 9 drugs in development for SCN2A-DEE across 1 company.

There are 1 clinical trial targeting SCN2A-DEE tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.